Literature DB >> 17928600

Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.

Keith Lindor1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17928600     DOI： 10.1056/NEJMct074694

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  28 in total

1.  Current status of therapy in autoimmune liver disease.

Authors:  Gideon M Hirschfield; Nadya Al-Harthi; E Jenny Heathcote
Journal:  Therap Adv Gastroenterol       Date:  2009-01       Impact factor: 4.409

2.  38-year-old woman with abnormal liver enzymes and hyperlipidemia.

Authors:  Marina G Silveira; Keith D Lindor
Journal:  Mayo Clin Proc       Date:  2009-06       Impact factor: 7.616

3.  Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis.

Authors:  Jesús M Banales; Elena Sáez; Miriam Uriz; Sarai Sarvide; Aura D Urribarri; Patrick Splinter; Pamela S Tietz Bogert; Luis Bujanda; Jesús Prieto; Juan F Medina; Nicholas F LaRusso
Journal:  Hepatology       Date:  2012-07-10       Impact factor: 17.425

4.  The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.

Authors:  Gideon M Hirschfield; Jessica K Dyson; Graeme J M Alexander; Michael H Chapman; Jane Collier; Stefan Hübscher; Imran Patanwala; Stephen P Pereira; Collette Thain; Douglas Thorburn; Dina Tiniakos; Martine Walmsley; George Webster; David E J Jones
Journal:  Gut       Date:  2018-03-28       Impact factor: 23.059

Review 5.  Therapeutic targeting of bile acids.

Authors:  Michael Camilleri; Gregory J Gores
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-07-02       Impact factor: 4.052

6.  Efficacy of ursodeoxycholic acid combined with Tongdan Decoction () on immunological indices and histopathological changes in primary biliary cirrhosis patients.

Authors:  Guang-Dong Tong; Hai-Hong Tang; Chun-Shan Wei; Ying-Jie Chen; Jin-Song He; Xiao-Zhou Zhou; Ying-Jun Zheng; Da-Qiao Zhou
Journal:  Chin J Integr Med       Date:  2012-01-10       Impact factor: 1.978

7.  Methotrexate in patients with primary biliary cirrhosis who respond incompletely to treatment with ursodeoxycholic acid.

Authors:  Marshall M Kaplan; Alan Bonder; Robin Ruthazer; Peter A L Bonis
Journal:  Dig Dis Sci       Date:  2010-06-18       Impact factor: 3.199

Review 8.  An update on the management of cholestatic liver diseases.

Authors:  Gautham Appanna; Yiannis Kallis
Journal:  Clin Med (Lond)       Date:  2020-09       Impact factor: 2.659

9.  Novel polymorphic human UDP-glucuronosyltransferase 2A3: cloning, functional characterization of enzyme variants, comparative tissue expression, and gene induction.

Authors:  Michael H Court; Suwagmani Hazarika; Soundararajan Krishnaswamy; Moshe Finel; J Andrew Williams
Journal:  Mol Pharmacol       Date:  2008-06-03       Impact factor: 4.436

10.  Coxiella burnetii as a possible cause of autoimmune liver disease: a case report.

Authors:  Chloe Kaech; Isabelle Pache; Didier Raoult; Gilbert Greub
Journal:  J Med Case Rep       Date:  2009-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.